Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

55.34 

0.16 0.3%

as of May 17 '21

52 Week Range:

35.24 56.82


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 9.62
10.10
11.26
12.46
14.57
14.90
34.30
27.62
20.17
20.44
17.77
growth rate 5.0% 11.5% 10.7% 16.9% 2.3% 130.2% -19.5% -27.0% 1.3% -13.1%
Earnings BIT 270.07
193.39
249.70
278.89
456.70
456.40
498.80
504.60
336.00
471.00
271.00
growth rate -28.4% 29.1% 11.7% 63.8% -0.1% 9.3% 1.2% -33.4% 40.2% -42.5%
Avg.PE 19.05
20.66
17.99
22.27
11.20
11.20
30.61
-15.37
-15.37
33.89
103.91
growth rate 8.5% -12.9% 23.8% -49.7% 0.0% 173.3% -100.0% 0.0% 100.0% 206.6%
ROA 8.37
6.10
6.46
6.23
6.64
5.55
5.35
-14.07
-10.61
3.04
-0.93
growth rate -27.1% 5.9% -3.6% 6.6% -16.4% -3.6% -100.0% 0.0% 100.0% -100.0%
ROE 14.47
13.26
15.49
13.20
13.30
10.78
8.23
-21.04
-17.23
5.15
-1.65
growth rate -8.4% 16.8% -14.8% 0.8% -19.0% -23.7% -100.0% 0.0% 100.0% -100.0%
ROIC 11.84
9.15
9.83
9.01
9.37
8.26
7.05
-16.93
-13.11
4.21
-0.69
growth rate -22.7% 7.4% -8.3% 4.0% -11.9% -14.7% -100.0% 0.0% 100.0% -100.0%
Cur. Ratio 3.65
1.40
1.20
1.44
1.85
2.51
2.44
2.09
1.86
2.01
1.36
growth rate -61.6% -14.3% 20.0% 28.5% 35.7% -2.8% -14.3% -11.0% 8.1% -32.3%
Quick Ratio 2.46
0.70
0.56
0.69
0.97
1.43
1.32
1.17
1.00
1.19
0.87
growth rate -71.5% -20.0% 23.2% 40.6% 47.4% -7.7% -11.4% -14.5% 19.0% -26.9%
Leverage 1.77
2.57
2.25
2.00
2.00
1.88
1.44
1.57
1.70
1.69
1.88
growth rate 45.2% -12.5% -11.1% 0.0% -6.0% -23.4% 9.0% 8.3% -0.6% 11.2%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 0.00
322.96
334.06
357.01
426.60
399.90
636.00
746.20
701.90
782.00
673.00
growth rate 3.4% 6.9% 19.5% -6.3% 59.0% 17.3% -5.9% 11.4% -13.9%
Acct.Payable 132.60
133.60
223.00
284.40
283.90
308.00
305.00
growth rate 0.8% 66.9% 27.5% -0.2% 8.5% -1.0%
Cur.Assets 992.96
764.84
838.99
863.68
1,207.00
1,196.70
1,743.50
2,002.50
1,888.00
2,000.00
1,791.00
growth rate -23.0% 9.7% 2.9% 39.8% -0.9% 45.7% 14.9% -5.7% 5.9% -10.5%
Total Assets 2,460.12
3,590.80
3,754.58
3,834.40
4,646.50
4,402.90
11,555.80
10,374.50
8,687.00
8,603.00
9,342.00
growth rate 46.0% 4.6% 2.1% 21.2% -5.2% 162.5% -10.2% -16.3% -1.0% 8.6%
Cash 407.75
58.22
60.48
56.63
151.60
284.60
383.90
320.60
309.60
405.00
438.00
growth rate -85.7% 3.9% -6.4% 167.7% 87.7% 34.9% -16.5% -3.4% 30.8% 8.2%
Inventory 233.10
273.20
304.23
331.19
387.10
340.40
517.10
623.10
598.90
562.00
466.00
growth rate 17.2% 11.4% 8.9% 16.9% -12.1% 51.9% 20.5% -3.9% -6.2% -17.1%
Cur.Liabilities 271.91
546.77
700.58
601.36
652.60
476.00
767.60
954.50
1,013.30
995.00
1,317.00
growth rate 101.1% 28.1% -14.2% 8.5% -27.1% 61.3% 24.4% 6.2% -1.8% 32.4%
Liabilities 1,071.18
2,195.30
2,086.79
1,920.22
2,324.30
2,063.50
3,429.90
3,746.60
3,554.00
3,508.00
4,372.00
growth rate 104.9% -4.9% -8.0% 21.0% -11.2% 66.2% 9.2% -5.1% -1.3% 24.6%
LT Debt 456.08
1,125.10
922.73
880.60
1,150.60
1,141.20
1,511.40
1,611.70
1,564.90
1,443.00
1,977.00
growth rate 146.7% -18.0% -4.6% 30.7% -0.8% 32.4% 6.6% -2.9% -7.8% 37.0%
Equity 1,388.93
1,395.50
1,667.79
1,914.25
2,321.30
2,338.00
8,114.30
6,616.30
5,121.10
5,093.00
4,967.00
growth rate 0.5% 19.5% 14.8% 21.3% 0.7% 247.1% -18.5% -22.6% -0.6% -2.5%
Common Shares 146.00
144.00
144.00
145.00
144.00
143.00
221.00
229.00
224.00
224.00
219.00
growth rate -1.4% 0.0% 0.7% -0.7% -0.7% 54.6% 3.6% -2.2% 0.0% -2.2%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures -2.72
-0.38
-0.76
-2.27
99.60
72.00
125.00
144.30
183.00
123.00
87.00
growth rate 0.0% 0.0% 0.0% 100.0% -27.7% 73.6% 15.4% 26.8% -32.8% -29.3%
Cash Dividends 21.97
21.60
23.71
26.35
37.30
40.00
64.60
78.30
79.00
81.00
88.00
growth rate -1.7% 9.8% 11.2% 41.5% 7.2% 61.5% 21.2% 0.9% 2.5% 8.6%
Cash From OA 285.05
297.13
279.16
315.48
560.40
497.40
563.40
601.90
500.00
633.00
635.00
growth rate 4.2% -6.1% 13.0% 77.6% -11.2% 13.3% 6.8% -16.9% 26.6% 0.3%
FCF per Share 1.66
1.59
1.30
1.61
2.43
3.08
1.75
1.61
1.34
1.58
2.13
growth rate -4.2% -18.2% 23.9% 50.9% 26.8% -43.2% -8.0% -16.8% 17.9% 34.8%
Sale Purchase of Stock 49.00
35.50
41.00
82.30
growth rate -27.6% 15.5% 100.7%
FCF 316.00
319.00
274.00
316.00
455.00
425.00
437.00
450.00
312.00
509.00
548.00
growth rate 1.0% -14.1% 15.3% 44.0% -6.6% 2.8% 3.0% -30.7% 63.1% 7.7%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 1,677.08
1,916.22
2,211.23
2,228.15
2,922.60
2,674.30
3,745.30
3,993.40
3,986.00
4,029.00
3,342.00
growth rate 14.3% 15.4% 0.8% 31.2% -8.5% 40.1% 6.6% -0.2% 1.1% -17.1%
Op.Income 287.16
227.06
288.37
316.54
456.70
456.40
498.80
504.60
336.00
471.00
271.00
growth rate -20.9% 27.0% 9.8% 44.3% -0.1% 9.3% 1.2% -33.4% 40.2% -42.5%
IBT 270.10
193.38
249.71
278.86
404.00
328.10
440.90
-1,603.50
-958.00
345.00
-60.00
growth rate -28.4% 29.1% 11.7% 44.9% -18.8% 34.4% -100.0% 0.0% 100.0% -100.0%
Net Income 200.63
184.62
237.25
236.50
322.90
251.20
429.90
-1,550.00
-1,011.00
263.00
-83.00
growth rate -8.0% 28.5% -0.3% 36.5% -22.2% 71.1% -100.0% 0.0% 100.0% -100.0%
EPS 1.82
1.70
2.18
2.16
2.24
1.76
1.94
-6.76
-4.51
1.17
-0.38
growth rate -6.6% 28.2% -0.9% 3.7% -21.4% 10.2% -100.0% 0.0% 100.0% -100.0%
Gross Profit 853.41
961.54
1,175.24
1,191.09
1,599.80
1,524.60
2,000.90
2,188.50
2,089.00
2,190.00
1,701.00
growth rate 12.7% 22.2% 1.4% 34.3% -4.7% 31.2% 9.4% -4.6% 4.8% -22.3%
R&D 80.80
74.90
128.50
151.70
161.00
131.00
115.00
growth rate -7.3% 71.6% 18.1% 6.1% -18.6% -12.2%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 237.10
72.80
-102.10
115.30
228.80
growth rate -69.3% -100.0% 100.0% 98.4%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 782.00
709.10
500.20
628.10
673.00
growth rate -9.3% -29.5% 25.6% 7.2%
Acct.Payable 307.90
271.10
214.10
242.80
305.00
growth rate -12.0% -21.0% 13.4% 25.6%
Cur.Assets 1,999.90
1,805.20
2,362.90
2,579.60
1,791.00
growth rate -9.7% 30.9% 9.2% -30.6%
Total Assets 8,602.90
8,058.40
8,604.20
8,895.90
9,342.00
growth rate -6.3% 6.8% 3.4% 5.0%
Cash 404.90
235.90
1,109.10
1,272.00
438.00
growth rate -41.7% 370.2% 14.7% -65.6%
Inventory 561.70
590.50
548.90
489.10
466.00
growth rate 5.1% -7.0% -10.9% -4.7%
Cur.Liabilities 995.50
891.50
763.00
1,178.20
1,317.00
growth rate -10.5% -14.4% 54.4% 11.8%
Liabilities 3,508.00
3,368.20
3,958.80
4,133.60
4,372.00
growth rate -4.0% 17.5% 4.4% 5.8%
LT Debt 1,442.60
1,449.60
2,182.70
1,930.00
1,977.00
growth rate 0.5% 50.6% -11.6% 2.4%
Equity 5,092.50
4,687.50
4,643.10
4,760.50
4,967.00
growth rate -8.0% -1.0% 2.5% 4.3%
Common Shares 2.60
2.60
2.60
2.60
3.00
growth rate 0.0% 0.0% 0.0% 15.4%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 36.00
25.60
13.20
21.20
27.00
growth rate -28.9% -48.4% 60.6% 27.4%
Cash Dividends 22.20
22.10
21.90
21.90
22.10
growth rate -0.5% -0.9% 0.0% 0.9%
Cash From OA 299.30
-10.70
175.10
207.10
263.50
growth rate -100.0% 100.0% 18.3% 27.2%
Sale Purchase of Stock
growth rate
FCF 263.30
-36.30
161.90
185.90
236.50
growth rate -100.0% 100.0% 14.8% 27.2%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 1,111.50
874.30
490.60
894.80
1,082.30
growth rate -21.3% -43.9% 82.4% 21.0%
Op.Income 237.10
72.80
-102.10
115.30
228.80
growth rate -69.3% -100.0% 100.0% 98.4%
IBT 137.50
-129.70
-119.90
66.70
122.90
growth rate -100.0% 0.0% 100.0% 84.3%
Net Income 102.30
-139.90
-95.40
53.80
98.50
growth rate -100.0% 0.0% 100.0% 83.1%
EPS
growth rate
Gross Profit 635.90
467.80
176.10
474.60
582.10
growth rate -26.4% -62.4% 169.5% 22.7%
R&D 131.30
115.00
115.00
115.00
115.00
growth rate -12.4% 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (13.02)

YOY Growth Grade:

E (18.04)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 103.91 -175.68 17.64
EPS / Growth -0.32

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.3% 6.3% 6.3%
Future PE 12.62 15.13 15.13
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.